SCHEMBL28533472

SCHEMBL28533472

O=C(O)C1=C(O)c2cc3cc(OCc4ccccc4)ccc3n2CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.53
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
ALOX5 P09917 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
MAOB P27338 1/20 0.42
DHODH Q02127 1/20 0.42
P2RY14 Q15391 1/20 0.42
NR4A2 P43354 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2017274 0.88 MEN1 (0.51) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL2021907 0.82 NPC1 (0.51) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL2016768 0.80 SRD5A2 (0.50) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL16918467 0.80 SRD5A2 (0.50) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL2016771 0.80 SRD5A2 (0.50) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL14327913 0.79 NPC1 (0.51) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL12320537 0.79 MEN1 (0.50) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL14327918 0.77 MEN1 (0.55) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL2019621 0.77 MAOB (0.51) SRD5A2MEN1KMT2ANPC1RAB9A
SCHEMBL2021475 0.77 SRD5A2 (0.49) SRD5A2MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105816453-B Substituted tricyclic acid derivatives as S1P1 receptor agonists for the treatment of autoimmune and inflammatory disorders 艾尼纳制药公司 2021-03-05 CN disclosed